|Articles|April 15, 2002
Vitrectomy presents clinical optionfor diffuse diabetic macular edema
Royal Oak, MI-Vitrectomy is a possible treatment for eyes with diffuse diabetic macular edema (DME) resulting from widespread breakdown of the blood-retinal barrier, according to Tarek Hassan, MD, co-director of the Vitreoretinal Programat Associated Retinal Consultants, Royal Oak, MI.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















